← Back to Analyst Consensus 
IGC Buy
IGC Pharma, Inc.
Current Price —
Implied Upside —
Analysts 5
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 18, 2026 (23 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 26, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Jun 8, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Apr 8, 2026 | Ascendiant Capital | maintain | Buy → Buy | — | 38% |
| Feb 23, 2026 | Ascendiant Capital | maintain | Buy → Buy | $5 | 38% |
| Dec 9, 2025 | Ascendiant Capital | maintain | Buy → Buy | $4.75 | 38% |
| Aug 26, 2025 | Ascendiant Capital | maintain | Buy → Buy | $4.5 | 38% |
| Mar 6, 2025 | Alliance Global Partners | reiterate | Buy → Buy | $3.5 | 41% |
| Feb 24, 2025 | Ascendiant Capital | maintain | Buy → Buy | $4.25 | 38% |
| Dec 5, 2024 | Ascendiant Capital | maintain | Buy → Buy | $4 | 38% |
| Sep 3, 2024 | Ascendiant Capital | maintain | Buy → Buy | $3.75 | 38% |
| Jul 29, 2024 | Ascendiant Capital | maintain | Buy → Buy | $3.5 | 38% |
| Jul 17, 2024 | Alliance Global Partners | initiate | — → Buy | $3.5 | 41% |
| Jun 21, 2024 | Ascendiant Capital | reiterate | Buy → Buy | $3.25 | 38% |
Price Target Trend
Apr 6, 2026 Oct 26, 2026
EPS Estimates
+1y —
0y —
0q —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days